5 BioPharma Catalysts Expected Around Christmas

By: via Benzinga
Biotech stocks are risky propositions that gyrate up and down violently in reaction to catalysts, including PDUFA dates, clinical ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.